Literature DB >> 12759259

Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS.

Eleanor S Roberts1, Michelle A Zandonatti, Debbie D Watry, Lisa J Madden, Steven J Henriksen, Michael A Taffe, Howard S Fox.   

Abstract

The etiology of the central nervous system (CNS) alterations after human immunodeficiency virus (HIV) infection, such as dementia and encephalitis, remains unknown. We have used microarray analysis in a monkey model of neuroAIDS to identify 98 genes, many previously unrecognized in lentiviral CNS pathogenesis, whose expression is significantly up-regulated in the frontal lobe of simian immunodeficiency virus-infected brains. Further, through immunohistochemical illumination, distinct classes of genes were found whose protein products localized to infiltrating macrophages, endothelial cells and resident glia, such as CD163, Glut5, and ISG15. In addition we found proteins induced in cortical neurons (ie, cyclin D3, tissue transglutaminase, alpha1-antichymotrypsin, and STAT1), which have not previously been described as participating in simian immunodeficiency virus or HIV-related CNS pathology. This molecular phenotyping in the infected brains revealed pathways promoting entry of macrophages into the brain and their subsequent detrimental effects on neurons. These data support the hypothesis that in HIV-induced CNS disease products of activated macrophages and astrocytes lead to CNS dysfunction by directly damaging neurons, as well as by induction of altered gene and protein expression profiles in neurons themselves which are deleterious to their function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759259      PMCID: PMC1868118          DOI: 10.1016/S0002-9440(10)64336-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  63 in total

1.  Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation.

Authors:  Georg F Weber; Samer Zawaideh; Sherry Hikita; Vikram A Kumar; Harvey Cantor; Samy Ashkar
Journal:  J Leukoc Biol       Date:  2002-10       Impact factor: 4.962

2.  Therapeutic effects of cystamine in a murine model of Huntington's disease.

Authors:  Alpaslan Dedeoglu; James K Kubilus; Thomas M Jeitner; Samantha A Matson; Misha Bogdanov; Neil W Kowall; Wayne R Matson; Arthur J L Cooper; Rajiv R Ratan; M Flint Beal; Steven M Hersch; Robert J Ferrante
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

3.  HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication.

Authors:  Claudia Cicala; James Arthos; Sara M Selig; Glynn Dennis; Douglas A Hosack; Donald Van Ryk; Marion L Spangler; Tavis D Steenbeke; Prateeti Khazanie; Neil Gupta; Jun Yang; Marybeth Daucher; Richard A Lempicki; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-27       Impact factor: 11.205

Review 4.  Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS.

Authors:  Kenneth C Williams; William F Hickey
Journal:  Annu Rev Neurosci       Date:  2002-03-27       Impact factor: 12.449

5.  Analysis of result variability from high-density oligonucleotide arrays comparing same-species and cross-species hybridizations.

Authors:  J D Chismar; T Mondala; H S Fox; E Roberts; D Langford; E Masliah; D R Salomon; S R Head
Journal:  Biotechniques       Date:  2002-09       Impact factor: 1.993

6.  Isolation and characterization of a human STAT1 gene regulatory element. Inducibility by interferon (IFN) types I and II and role of IFN regulatory factor-1.

Authors:  Lee H Wong; Helena Sim; Moitreyee Chatterjee-Kishore; Irene Hatzinisiriou; Rodney J Devenish; George Stark; Stephen J Ralph
Journal:  J Biol Chem       Date:  2002-03-21       Impact factor: 5.157

7.  Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression.

Authors:  A Nishiyama; M Matsui; S Iwata; K Hirota; H Masutani; H Nakamura; Y Takagi; H Sono; Y Gon; J Yodoi
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

8.  Identification of signal peptide peptidase, a presenilin-type aspartic protease.

Authors:  Andreas Weihofen; Kathleen Binns; Marius K Lemberg; Keith Ashman; Bruno Martoglio
Journal:  Science       Date:  2002-06-21       Impact factor: 47.728

9.  Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses.

Authors:  Erika Geimonen; Sherry Neff; Tracy Raymond; Salih S Kocer; Irina N Gavrilovskaya; Erich R Mackow
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

10.  Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress.

Authors:  Mauro Piacentini; Maria Grazia Farrace; Lucia Piredda; Paola Matarrese; Fabiola Ciccosanti; Laura Falasca; Carlo Rodolfo; Anna Maria Giammarioli; Elisabetta Verderio; Martin Griffin; Walter Malorni
Journal:  J Neurochem       Date:  2002-06       Impact factor: 5.372

View more
  96 in total

Review 1.  Expression profile analysis of neurodegenerative disease: advances in specificity and resolution.

Authors:  Jason G Glanzer; Phillip G Haydon; James H Eberwine
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

2.  Antigen-specific gene expression profiles of peripheral blood mononuclear cells do not reflect those of T-lymphocyte subsets.

Authors:  Paul J McLaren; Michael Mayne; Stuart Rosser; Teri Moffatt; Kevin G Becker; Francis A Plummer; Keith R Fowke
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

Review 3.  Editorial neuroAIDS review.

Authors:  Paul Shapshak; Pandjassarame Kangueane; Robert K Fujimura; Deborah Commins; Francesco Chiappelli; Elyse Singer; Andrew J Levine; Alireza Minagar; Francis J Novembre; Charurut Somboonwit; Avindra Nath; John T Sinnott
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

4.  Altered central nervous system gene expression caused by congenitally acquired persistent infection with lymphocytic choriomeningitis virus.

Authors:  Stefan Kunz; Jillian M Rojek; Amanda J Roberts; Dorian B McGavern; Michael B A Oldstone; Juan Carlos de la Torre
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.

Authors:  Rebecca Craig-Schapiro; Richard J Perrin; Catherine M Roe; Chengjie Xiong; Deborah Carter; Nigel J Cairns; Mark A Mintun; Elaine R Peskind; Ge Li; Douglas R Galasko; Christopher M Clark; Joseph F Quinn; Gina D'Angelo; James P Malone; R Reid Townsend; John C Morris; Anne M Fagan; David M Holtzman
Journal:  Biol Psychiatry       Date:  2010-11-15       Impact factor: 13.382

Review 6.  Biomarkers for neuroAIDS: the widening scope of metabolomics.

Authors:  Gurudutt Pendyala; Elizabeth J Want; William Webb; Gary Siuzdak; Howard S Fox
Journal:  J Neuroimmune Pharmacol       Date:  2006-10-10       Impact factor: 4.147

7.  Host and virus strain dependence in activation of human macrophages by human immunodeficiency virus type 1.

Authors:  Katarzyna Kazmierczak; Mary Jane Potash
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

Review 8.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

9.  Transcriptome analysis of HIV-infected peripheral blood monocytes: gene transcripts and networks associated with neurocognitive functioning.

Authors:  Andrew J Levine; Steve Horvath; Eric N Miller; Elyse J Singer; Paul Shapshak; Gayle C Baldwin; Otoniel Martínez-Maza; Mallory D Witt; Peter Langfelder
Journal:  J Neuroimmunol       Date:  2013-09-26       Impact factor: 3.478

10.  Leishmania major abrogates gamma interferon-induced gene expression in human macrophages from a global perspective.

Authors:  Nisha Dogra; Corinna Warburton; W Robert McMaster
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.